Osteoclasts, blasts, and cytes Flashcards
The cell in bone that is responsible for resorbing (removing) bone. It is a multinucleated cell of hematopoietic origin (macrophage/monocyte lineage)
Osteoclast
The cell in bone that is responsible for forming new bone. It is of mesenchymal origin
Osteoblast
The cell that is embedded in the mineralized bone matrix. It is derived from an osteoblast which has become entrapped in the mineralized bone.
Osteocyte
the process by which mature/damaged bone is removed by osteoclasts and replaced with new bone (i.e. bone is replaced but there is no net gain)
Bone remodeling
the process by which bone size/shape is changed by independent actions of osteoblasts and osteoclasts (e.g. adding new bone without prior resorption or removing bone without replacing it). Can occur during longitudinal growth of bone or in response to an increase in mechanical loading of the bone. Modeling can lead to a net gain or loss of bone.
Bone modeling
A disease of impaired mineralization due to mutations in the gene for alkaline phosphatase (TNSALP) that results in reduced amounts or no alkaline phosphatase.
Hypophosphatasia
A disease due to mutations in the RUNX2 gene. Patients have partly or completely missing clavicles and supernumerary teeth.
Cleidocranial Dysplasia
(A.k.a. “Stone man syndrome”) – a disease in which there is ectopic mineralization in non-skeletal soft tissues, leading to sheets, plates of bones forming across the ribs, joints, etc. This restricts the movement of the skeleton. The disease is due to mutations in the BMP type I receptor (ACVR1) that make it hyperresponsive to BMP ligands.
Fibrodysplasia Ossificans Progressiva
These are diseases due to mutations in the gene for sclerostin (SOST). Reduced amounts of sclerostin lead to increased bone mass.
Sclerostosis and Van Buchem’s disease
a disease of impaired osteoclast function that leads to bones that are abnormally dense but brittle and prone to fracture. The disorder is caused by mutations in genes important for osteoclast resorption.
Osteopetrosis
a disease of low bone mass that occurs due to the inability of bone formation to keep up with bone resorption (i.e. not all the bone that is resorbed is replaced, so there is a net loss in bone mass). Usually seen in post-menopausal women and/or the aged population (male and female).
Osteoporosis
a drug that inhibits bone resorption
Anti-resorptive agent
a drug that stimulates bone formation
Bone anabolic agent
a fancy word for bone that forms in the wrong place
Heterotopic bone formation
a fancy word for a cell that can sense mechanical (deformation) input
Mechanosensor
a fancy word for bone that is dead and does not have viable osteocytes
Osteonecrotic bone
Osteoblasts, chondrocytes, myoblasts, and adipocytes differentiate from a __________ precursor
common mesenchymal precursor
_____ produces large amounts of ECM proteins (mainly collagen type 1) which then mineralizes (osteoid); the lifespa is weeks
osteoblasts
RUNX2 and Osterix seen in osteoblasts are ____
transcription factors
Alkaline phosphatase seen in osteoblasts are
enzymes
Type 1 collagen, osteopontin, osteocalcin, and bone sialoprotein seen in osteoblasts are
ECM proteins
___ is a master TF for bone; essential bone and tooth development; heterozygous mutation of _____ in humans results in cleidocranial dysplasia (CCD)
RUNX2
_____ is autosomal dominant mutation characterized by haploinsufficiency of RUNX2; clavicles partly or completely missing, supernumerary teeth, prognathic mandible due to hypoplasia of maxilla
Cleidocranial dysplasia